Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
| General Information of Drug (ID: DR1927) | ||||||
|---|---|---|---|---|---|---|
| Drug Name |
SQ-32709
|
|||||
| Synonyms |
Sq 32709; all-trans-Farnesyl pyrophosphate; farnesyl diphosphate; farnesyl pyrophosphate; farnesyl-PP; trans,trans-Farnesyl diphosphate; trans-Farnesyl pyrophosphate; trans-trans-farnesyl diphosphate; (2E,6E)-Farnesyl diphosphate; (2E,6E)-Farnesyl pyrophosphate; (E,E)-Farnesyl diphosphate; (E,E)-Farnesyl pyrophosphate; (all-E)-Farnesyl diphosphate; 2-trans,6-trans-Farnesyl pyrophosphate; 2-trans,6-trans-farnesyl diphosphate; CHEBI:17407; CHEMBL69330; UNII-79W6B01D07; trans,trans-Farnesyl pyrophosphate
|
|||||
| Indication | Arteriosclerosis obliterans [ICD11: BD40] | Discontinued | [1] | |||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| Pharmaceutical Properties | Molecular Weight | 382.33 | Topological Polar Surface Area | 113 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 11 | |||
| Hydrogen Bond Donor Count | 3 | Hydrogen Bond Acceptor Count | 7 | |||
| Cross-matching ID |
|
|||||
| Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.


